Mumbai Sterilisation Statistics Reveal Gender Gap, Urge Workplaces to Rethink Health Policies

Lead paragraph
Mumbai’s latest health statistics reveal a stark gender imbalance in sterilisation procedures: out of 34,805 surgeries carried out by the Brihanmumbai Municipal Corporation (BMC) between 2022 and 2025, men accounted for a meagre 4%, while women dominated at 96%. This trend echoes a long‑standing disparity and raises questions for workplaces, public health policymakers and the city’s workforce, including a growing cohort of international students and expatriate professionals.

Background / Context

Over the past decade, Mumbai has seen a steady decline in birth rates, attributed in part to wider adoption of contraceptives and changing social attitudes. In 2024, the BMC’s Ministry of Health reported that 33,338 women underwent sterilisation, contrasted with a mere 1,374 male vasectomies. The gap is not new; historically men have been underrepresented in permanent birth control measures. However, the sheer scale of the numbers in the current reporting period—almost 35,000 procedures—has drawn public attention and academic scrutiny.

Compounded by the fact that men receive a higher financial incentive per procedure (₹1,451 vs ₹250 for women), the disparity suggests deeper systemic pressures. It also coincides with a surge in temporary contraceptive uptake: 10,175 women received Antara injectable shots, while 61,353 were fitted with copper‑T intrauterine devices. Meanwhile, over five million condoms are distributed annually by the municipal council, yet data on actual usage remains scarce and fragmented.

Key Developments

1. Statistical revelation – According to BMC health data, the Mumbai sterilisation gender gap reached its widest point in the last quarter of 2025, with men forming only 4% of all procedures performed. The count comprises 1,374 male vasectomies and 1,000 male tubal ligations, underscoring procedural misclassification.

2. Incentive parity – The BMC offered higher remuneration to male patients, aiming to offset perceived higher procedural risk. Yet, despite the ₹1,451 reward, participation remained minimal, indicating non‑financial barriers.

3. Provider perspectives – Dr. Rahul Mayekar of Sion Hospital argued that male sterilisation is “far easier”—a ten‑minute outpatient procedure—yet patients are deterred by societal expectations of masculinity. “The skewed numbers are a result of the medieval or chauvinistic mindset that men usually have, combined with misconceptions and stigma around sterilisation,” he said.

4. Temporary male contraceptives – Current market options in India are limited to condoms, which, despite being widely distributed, suffer from inconsistent usage. Male contraceptive pills are still under investigation, with research conducted primarily overseas. This leaves male workers with few effective, non‑surgical options.

Impact Analysis

For employees across Mumbai’s diverse industries—manufacturing, IT, hospitality, and education—the gender gap has concrete implications:

• Workplace health policies – Employers offering reproductive health benefits may need to widen coverage to include male contraception counselling and access to vasectomy clinics, ensuring equitable benefits.
• Public health planning – A persistent gap indicates under‑utilised healthcare resources. Public health officials risk over‑allocating funds on women’s permanent contraception while neglecting male options.
• Student welfare – International students, especially those from regions with limited reproductive health services, face increased uncertainty. Universities must collaborate with health departments to provide comprehensive contraceptive education, including male options.
• Workforce productivity – Unplanned pregnancies can affect employee turnover and productivity. Balanced access to all contraceptive options may improve workforce stability.

Ultimately, the gender gap reflects broader social dynamics: entrenched gender roles, misinformation, and a scarcity of male contraceptive choices. It affects not only individuals but corporate HR policies and municipal health budgets.

Expert Insights / Tips

1. Re‑evaluate incentive schemes – Instead of higher cash rewards for men, BMC could implement community outreach programs that destigmatise male participation. Educational campaigns featuring male role models and peer‑led workshops could boost uptake.

2. Integrate male counselling into workplace health seminars – Corporate wellness programmes should include brief educational sessions on vasectomy risks and benefits, as well as emerging male contraceptives. This can shift cultural perceptions and normalize male decision‑making in family planning.

3. Strengthen data transparency – Employers and health boards should publish separate statistics for male and female procedures, enabling targeted interventions. Data gaps—such as condom distribution versus usage—must be bridged through real‑time digital reporting kiosks.

4. International student support – Universities and student housing authorities can partner with local clinics to provide subsidised vasectomy consultations. Multilingual information packets can address linguistic barriers among foreign students.

5. Advocacy for product development – NGOs and industry groups should lobby for accelerated approval of male contraceptive pills in India, citing the current lack of options and the gender imbalance highlighted in BMC’s data.

Looking Ahead

In the next fiscal year, BMC plans to re‑audit its contraceptive distribution model to account for gender disparities. The municipal government is also exploring a pilot programme at two major hospitals, offering free vasectomies to employees of government agencies, with the aim of increasing male participation to at least 10% of overall sterilisation cases.

On a national level, the Ministry of Women and Child Development has pledged to incorporate male contraceptive research into the National Health Mission. If successful, India could become a leader in male family‑planning options, potentially reducing the sterilisation gender gap across the country.

Workplaces must prepare by revisiting health insurance formularies, ensuring that male contraceptive counselling and vasectomy procedures are covered under their employee benefits. Moreover, educational institutions should embed reproductive health modules into orientation programmes for international students, fostering informed decision‑making early on.

In sum, the Mumbai sterilisation gender gap is not just a public health statistic—it is a mirror reflecting societal beliefs, policy priorities, and workplace practices. Addressing it will require coordinated action from health authorities, employers, educational institutions, and advocacy groups alike.

Reach out to us for personalized consultation based on your specific requirements.